Literature DB >> 11389726

Ets1 is a common element in directing transcription of the alpha and beta genes of human protein kinase CK2.

A Krehan1, R Schmalzbauer, O Böcher, K Ackermann, U Wirkner, S Brouwers, W Pyerin.   

Abstract

Protein kinase CK2 is a conserved and vital Ser/Thr phosphotransferase with various links to malignant diseases, occurring as a tetramer composed of two catalytically active (CK2alpha and/or CK2alpha') and two regulatory subunits (CK2beta). There is balanced availability of CK2alpha and CK2beta transcripts in proliferating and differentiating cultured cells. Examination of the human CK2beta gene for transcriptionally active regions by systematic deletions and reporter gene assays indicates strong promoter activity at positions -42 to 14 and 12 to 72 containing transcription start sites 1 and 2 of the gene (positions +1 and 33), respectively, an upstream and a downstream enhancer activity at positions -241 to -168 and 123 to 677, respectively, and silencer activity at positions -241 to -261. Of the various transcription factor binding motifs present in those regions, Ets1 and CAAT-related motifs turned out to be of particular importance, Ets1 for promoter activation and CAAT-related motifs for enhancer activation. In addition, there are contributions by Sp1. Most strikingly, the Ets1 region representing two adjoining consensus motifs also occurs with complete identity in the recently characterized promoter of the CK2alpha gene [Krehan, A., Ansuini, H., Böcher, O., Grein, S., Wirkner, U. & Pyerin, W. (2001) J. Biol. Chem. 275, 18327-18336], and affects comparably, when assayed in parallel, the promoters of both CK2 genes, both by motif mutations and by Ets1 overexpression. The data strongly support the hypothesis that Ets1 acts as a common regulatory element of the CK2alpha and CK2beta genes involved in directing coordinate transcription and contributing to the balanced availability of transcripts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389726     DOI: 10.1046/j.1432-1327.2001.02219.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Transcriptional coordination of the genes encoding catalytic (CK2alpha) and regulatory (CK2beta) subunits of human protein kinase CK2.

Authors:  W Pyerin; K Ackermann
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

2.  CK2 kinase activity but not its binding to CK2 promoter regions is implicated in the regulation of CK2α and CK2β gene expressions.

Authors:  Sarah Lupp; Catalina Gumhold; Emmanuel Ampofo; Mathias Montenarh; Karen Rother
Journal:  Mol Cell Biochem       Date:  2013-08-21       Impact factor: 3.396

3.  Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines.

Authors:  Claudia Götz; Sabine Kartarius; Sarah Schetting; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  The catalytic subunit alpha' gene of human protein kinase CK2 (CSNK2A2): genomic organization, promoter identification and determination of Ets1 as a key regulator.

Authors:  Karin Ackermann; Tanja Neidhart; Jochen Gerber; Andrea Waxmann; Walter Pyerin
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

5.  Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cells.

Authors:  Mei-Chuan Chen; Chun-Han Chen; Hsiao-Ching Chuang; Samuel K Kulp; Che-Ming Teng; Ching-Shih Chen
Journal:  Hepatology       Date:  2011-01       Impact factor: 17.425

6.  Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation.

Authors:  S Koch; C T Capaldo; R S Hilgarth; B Fournier; C A Parkos; A Nusrat
Journal:  Mucosal Immunol       Date:  2012-07-04       Impact factor: 7.313

7.  The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta.

Authors:  Ashley C Bibby; David W Litchfield
Journal:  Int J Biol Sci       Date:  2005-04-01       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.